Also trades as: NAMSW (NASDAQ) · $vol 0M
NAMS Earnings
NewAmsterdam Pharma Company N.V.
1W: +2.8%
1M: -9.3%
3M: -33.5%
YTD: -34.1%
1Y: -21.0%
3Y: +154.9%
5Y: +135.5%
$23.20
-0.96 (-3.97%)
Weekly Expected Move ±8.4%
$19
$21
$23
$25
$27
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Last Earnings
2026-08-05
EPS
$-0.52
▼ Miss -7.9%
Revenue
$4M
▲ Beat +30.7%
Next Earnings
2026-11-04
EPS Estimate
$-0.45
Range: $-0.63 - $-0.32
Revenue Estimate
$16M
9 analysts
Estimate vs Actual
Earnings Surprise History
6/19
EPS Beats
7/19
Revenue Beats
32%
EPS Beat Rate
37%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | annual | 2029-12-31 | $1.45 | $1.45 | — | $766,994,917 | $766,995,650 |
| 2026-10-02 | quarter | 2027-12-30 | $-0.29 | $-0.29 | — | $64,376,000 | $64,377,600 |
| 2026-10-02 | quarter | 2026-09-30 | $-0.49 | $-0.49 | — | $7,540,109 | $7,540,109 |
| 2026-10-02 | quarter | 2026-12-30 | $-0.45 | $-0.45 | — | $15,791,909 | $15,791,909 |
| 2026-10-02 | quarter | 2027-03-30 | $-0.59 | $-0.59 | — | $1,620,000 | $1,617,280 |
| 2026-10-02 | annual | 2026-12-31 | $-1.89 | $-1.89 | — | $30,260,781 | $30,263,192 |
| 2026-10-02 | annual | 2027-12-31 | $-1.56 | $-1.56 | — | $153,245,860 | $153,248,435 |
| 2026-10-02 | quarter | 2027-06-30 | $-0.61 | $-0.61 | — | $2,480,000 | $2,489,700 |
| 2026-10-02 | quarter | 2027-09-30 | $-0.50 | $-0.50 | — | $24,120,000 | $24,125,640 |
| 2026-10-02 | annual | 2028-12-31 | $-0.42 | $-0.42 | — | $394,704,575 | $394,704,389 |
| 2026-09-30 | annual | 2027-12-31 | $-1.57 | $-1.56 | ▲ 0.01 | $153,245,860 | $153,245,860 |
| 2026-09-25 | quarter | 2026-06-30 | $-0.48 | $-0.48 | — | $2,830,250 | $1,877,143 |
| 2026-09-23 | quarter | 2026-09-30 | $-0.49 | $-0.49 | — | $7,540,109 | $7,540,109 |
| 2026-09-23 | quarter | 2026-12-30 | $-0.46 | $-0.45 | ▲ 0.01 | $15,791,909 | $15,791,909 |
| 2026-09-23 | annual | 2026-12-31 | $-1.89 | $-1.89 | — | $30,263,192 | $30,260,781 |
Earnings Call Transcripts
No transcripts available.